ACD/Labs Unveils Spectrus Platform 2024: AI-Driven Solutions for Enhanced R&D

ACD/Labs, a leader in informatics solutions, has launched version 2024 of its Spectrus Platform applications, designed to support digitalized research and development (R&D). This latest release is equipped with AI tools that further enhance data analysis capabilities, particularly in pharmaceutical process development, chemistry manufacturing and control (CMC), and high throughput experimentation (HTE).

As organizations prioritize digital transformation, ACD/Labs continues to provide innovative solutions to normalize and contextualize complex data for use in AI/ML-driven applications. The 2024 version also delivers key enhancements to software like Luminata® and Katalyst D2D®, improving lab productivity and ensuring data integrity.

Key Features of Spectrus Platform 2024:

• AI-Enhanced Integration: Automates data normalization for AI/ML applications.
• Improved Software Integration: Seamless communication with third-party systems.
• Accelerated Stability Study Support: Optimizes drug shelf life and expiry determination.
• Advanced NMR and MS Analysis: Enhanced qualitative and quantitative analysis capabilities.
• Browser-Based Data Tools: Expanded functionality in Spectrus Processor JS and Spectrus Manager JS.

By continuing to modernize its software stack, ACD/Labs is positioned to meet the evolving needs of R&D labs, especially in life sciences, where data-driven decision-making is key to innovation.